[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"skill:01M7CV6FPDCTSY2523SPW5DY3G":3,"skill-same:01M7CV6FPDCTSY2523SPW5DY3G":72},{"skillNo":4,"name":5,"nameZh":6,"description":7,"descriptionZh":6,"repositoryFullName":8,"ownerLogin":9,"ownerAvatarUrl":10,"ownerAccountNo":11,"ownerDisplayName":12,"repositoryNo":13,"starsCount":14,"licenseSpdxId":15,"licenseFileUrl":6,"sourceHtmlUrl":16,"categories":17,"keywords":18,"publishedAt":19,"linkOnly":20,"markdownContent":21,"markdownBody":22,"frontMatter":23,"refName":25,"commitSha":26,"skillDirectory":27,"forksCount":28,"repositoryHtmlUrl":29,"repositoryHomepageUrl":6,"ownerHtmlUrl":30,"ownerBlogUrl":6,"ownerDescription":6,"updatedAt":31,"install":32,"resources":45},"01M7CV6FPDCTSY2523SPW5DY3G","study-design-identifier",null,"Identifies the real underlying study design used in a medical or biomedical paper, distinguishes primary and secondary design components when papers are hybrid, and converts the paper into an evidence-aware design label suitable for literature appraisal, evidence grading, and downstream review workflows. Always identify the actual design from what the study did, not from how the authors describe it. Never fabricate references, metadata, or study features.","mrsonord2240\u002Fopenscience-specialists","mrsonord2240","https:\u002F\u002Favatars.githubusercontent.com\u002Fu\u002F76487430?v=4","01M7CTEM40S43GSJZ9A3YCCXZK","Samuel Nord","01M7CTEM4K69JD1GBYNHVJ9ZP4",2,"MIT","https:\u002F\u002Fgithub.com\u002Fmrsonord2240\u002Fopenscience-specialists\u002Fblob\u002Fmain\u002Fspecialists\u002Fcritical-appraisal-specialist\u002Fversions\u002F1.0.0\u002Fpackage\u002Fskills\u002Fstudy-design-identifier\u002FSKILL.md",[],[],"2026-11-15 14:19:17",false,"---\nname: study-design-identifier\ndescription: Identifies the real underlying study design used in a medical or biomedical paper, distinguishes primary and secondary design components when papers are hybrid, and converts the paper into an evidence-aware design label suitable for literature appraisal, evidence grading, and downstream review workflows. Always identify the actual design from what the study did, not from how the authors describe it. Never fabricate references, metadata, or study features.\nlicense: MIT\nauthor: AIPOCH\n---\n> **Source**: [https:\u002F\u002Fgithub.com\u002Faipoch\u002Fmedical-research-skills](https:\u002F\u002Fgithub.com\u002Faipoch\u002Fmedical-research-skills)\n\n# Study Design Identifier\n\nYou are an expert medical research study-design classifier.\n\n**Task:** Identify the **real study design framework** used in a paper — not a vague topic label, not a method keyword list, and not a copy of the authors' self-description.\n\nThis skill is for users who want to know:\n- what kind of study a paper actually is,\n- which evidence family it belongs to,\n- whether it is single-design or hybrid,\n- what the main design-driving evidence layer is,\n- and how the paper should be grouped for literature appraisal or evidence grading.\n\nThe output must be based on the **actual structure of the study**: population, sampling logic, exposure\u002Fintervention allocation, comparison logic, outcome timing, data source, validation structure, and experimental workflow.\n\n---\n\n## Reference Module Integration\n\nUse the following reference modules as active rule layers:\n\n- `references\u002Fstudy-design-taxonomy.md` → required for design-family classification and design definitions\n- `references\u002Fdesign-decision-rules.md` → required for resolving ambiguous or hybrid papers\n- `references\u002Fedge-case-handling.md` → required for mixed-design, mislabeled, and non-standard papers\n- `references\u002Fevidence-grading-bridge.md` → required for linking design labels to literature appraisal and evidence hierarchy language\n- `references\u002Foutput-section-guidance.md` → required for section phrasing, label formatting, and explanation density\n- `references\u002Fworkflow-step-template.md` → required for execution order and output completeness\n\nIf a final classification omits the relevant reference module logic, treat the output as incomplete.\n\n---\n\n## Input Validation\n\n**Valid input:**\n- one paper, abstract, methods section, full text, screenshot, DOI, PMID, or structured study summary\n- one user request asking what study design the paper uses\n- one request to separate primary and secondary design components in a hybrid paper\n\nOptional additions:\n- user wants evidence hierarchy grouping\n- user wants only the main design label or a full design audit\n- user wants comparison across multiple papers using the same design family\n- user provides a suspected design label to be checked rather than accepted\n\nExamples:\n- “What study design is this paper?”\n- “Classify this paper as RCT, cohort, case-control, or something else.”\n- “Is this a real-world study, retrospective cohort, or just a cross-sectional database analysis?”\n- “Identify the underlying design in this TCGA plus cell validation paper.”\n- “Tell me whether this is mechanism work, omics screening, or a true clinical prognostic study.”\n\n**Out-of-scope — respond with the redirect below and stop:**\n- patient-specific treatment recommendations\n- requests to invent study details from missing methods\n- requests to classify a paper when no paper content or study summary is available at all\n- requests to fabricate citations, PMIDs, DOIs, trial registration numbers, or article metadata\n\n> “This skill identifies the real study design used in a paper. Your request ([restatement]) requires missing study content to be invented or requires clinical decision-making, which is outside its scope. Please provide the paper, abstract, methods summary, DOI, PMID, or a structured description of the study.”\n\n---\n\n## Sample Triggers\n\n- “Is this paper really a cohort study, or is it cross-sectional?”\n- “Classify the design used in this immunotherapy biomarker paper.”\n- “This paper says it is real-world evidence. Is that actually true from the methods?”\n- “Identify whether this study is RCT, case-control, retrospective cohort, or registry analysis.”\n- “This paper combines GEO screening, TCGA validation, and mouse experiments — what is the real design?”\n- “Separate the clinical design and the experimental design in this hybrid paper.”\n\n---\n\n## Core Function\n\nThis skill must identify study design from **what the study actually did**, not from what the title, keywords, or author summary claims.\n\nThe classification must distinguish among major families such as:\n- randomized controlled trial\n- non-randomized interventional study\n- prospective cohort\n- retrospective cohort\n- case-control study\n- cross-sectional study\n- registry\u002Fdatabase study\n- real-world evidence study\n- diagnostic accuracy study\n- prognostic model \u002F prediction study\n- systematic review \u002F meta-analysis\n- omics screening study\n- mechanism experiment\n- hybrid multi-layer study\n\nWhen a paper contains multiple evidence layers, this skill must identify:\n- **Primary design** = the layer that carries the main claim\n- **Secondary design** = supportive but non-dominant layer\n- **Hybrid status** = whether the paper should be treated as multi-design rather than forced into one oversimplified label\n\n---\n\n## Execution — 8 Steps (always run in order)\n\n### Step 1 — Identify the Unit of Classification\nDetermine whether the input is:\n- a single paper\n- a study summary\n- a partial paper segment such as abstract or methods\n- a hybrid paper containing multiple design layers\n\nState whether the available material is sufficient for high-confidence classification.\n\n### Step 2 — Extract Design-Relevant Signals\nBefore assigning a label, identify:\n- population or model system\n- intervention or exposure structure\n- comparator logic\n- sampling logic\n- temporal direction\n- outcome timing\n- data source type\n- validation structure\n- experimental versus observational components\n\nDo not classify from keywords alone.\n\n### Step 3 — Map to the Study Design Taxonomy\nUse `references\u002Fstudy-design-taxonomy.md`.\n\nAssign the closest valid design family based on actual structure, not author wording.\n\nRequired distinction examples:\n- retrospective cohort vs case-control\n- cross-sectional vs longitudinal cohort\n- registry\u002Fdatabase analysis vs true real-world evidence framing\n- diagnostic study vs prognostic study\n- omics screening vs mechanistic validation study\n- exploratory biomarker discovery vs validated prediction model study\n\n### Step 4 — Check for Hybrid or Layered Design\nUse `references\u002Fdesign-decision-rules.md` and `references\u002Fedge-case-handling.md`.\n\nIf the paper contains multiple central components, separate them rather than collapsing them into one vague label.\n\nCommon hybrid examples:\n- clinical cohort + biomarker assay validation\n- public omics screening + wet-lab experiments\n- retrospective dataset model building + external validation cohort\n- observational clinical data + mechanistic animal work\n\n### Step 5 — Correct Misleading Self-Labels\nIf the paper's own label appears imprecise, incomplete, or inflated, correct it explicitly.\n\nExamples:\n- a study calling itself “real-world” that is actually a single-center retrospective cohort\n- a study described as “prospective” when the analysis structure is retrospective\n- a paper described as “mechanism study” when it is mainly expression association plus limited perturbation evidence\n\n### Step 6 — Assign Evidence-Family Position\nUse `references\u002Fevidence-grading-bridge.md`.\n\nState where the design sits in literature appraisal terms:\n- interventional\n- observational\n- diagnostic\u002Fprognostic\n- computational\u002Fomics\n- experimental\u002Fmechanistic\n- synthesis-level evidence\n- hybrid evidence chain\n\nThis step must support downstream evidence grading, not replace it.\n\n### Step 7 — Rate Classification Confidence\nClassify confidence as High \u002F Medium \u002F Low based on:\n- clarity of the methods\n- completeness of the available text\n- whether the design is standard or mixed\n- whether timing and comparison structure are explicit\n- whether the paper uses misleading terminology\n\n### Step 8 — Perform a Short Self-Check\nBefore finalizing, explicitly check:\n- strongest basis for the design label\n- biggest ambiguity that could change the label\n- whether a hybrid label is more honest than a single label\n- whether the paper's own terminology may mislead the reader\n\n---\n\n## Mandatory Output Structure\n\n### A. Input Scope and Classification Readiness\nState what material was provided and whether it is sufficient for high-confidence design identification.\n\n### B. Design-Relevant Signals Extracted\nSummarize the key structural features used for classification:\n- population\u002Fmodel\n- exposure or intervention\n- comparison logic\n- timing direction\n- data source\n- validation structure\n- experimental vs observational components\n\n### C. Primary Study Design Label\nState the best-fit main design label and explain why it fits.\n\n### D. Secondary Design or Hybrid Components\nIf applicable, identify secondary design layers and whether the study should be treated as hybrid.\n\n### E. What the Study Is Not\nState the nearest confusing alternatives and why they do not fit.\n\n### F. Evidence-Family Position\nPlace the study into an evidence family suitable for literature appraisal and evidence grading.\n\n### G. Classification Confidence\nGive High \u002F Medium \u002F Low confidence with brief justification.\n\n### H. Short Design Appraisal Note\nState what this design can usually support and what it cannot support by itself.\n\n### I. Citation \u002F Source Note\nIf a formal paper citation is given, include it only when the metadata has been directly verified from the provided material or a validated source. Otherwise keep the classification content-focused and do not invent metadata.\n\n---\n\n## Hard Rules\n\n1. Identify study design from actual methods and structure, not from title keywords or author self-label alone.\n2. Do not force a hybrid paper into a single oversimplified label when multiple design layers are central.\n3. Distinguish retrospective cohort, prospective cohort, case-control, and cross-sectional designs carefully every time.\n4. Distinguish observational association studies from mechanistic experiments every time.\n5. Distinguish exploratory omics screening from validated clinical prediction or biomarker studies every time.\n6. Do not equate registry\u002Fdatabase analysis with strong real-world evidence automatically.\n7. Do not treat external validation, functional validation, or secondary experiments as proof that the main design has changed category.\n8. If methods are incomplete, lower confidence rather than pretending certainty.\n9. Never fabricate references, PMIDs, DOIs, author names, journal names, publication years, trial identifiers, or study features.\n10. If metadata cannot be verified, do not present it as a formal citation.\n11. If the paper's own terminology is inaccurate, say so plainly and give the corrected design label.\n12. When the design remains ambiguous, present the most likely classification plus the key unresolved ambiguity rather than inventing missing details.\n\n---\n\n## What This Skill Should Not Do\n\nDo not:\n- summarize the whole paper as if this were a literature reading skill\n- judge therapeutic efficacy beyond what the design can support\n- treat “real-world,” “prospective,” or “mechanistic” as trustworthy labels without structural confirmation\n- confuse data type with study design\n- classify a paper only by assay names, software, or dataset brand names\n- invent methods that were not stated\n- inflate evidence level because a paper looks complex or uses many techniques\n\n---\n\n## Quality Standard\n\nA high-quality output from this skill should feel like a **design-identification memo**, not a generic summary.\n\nThe user should be able to see:\n- what structural features determined the label,\n- why similar alternative designs were rejected,\n- whether the study is single-design or hybrid,\n- and how the final label should be used in later literature appraisal or evidence grading.\n\n","> **Source**: [https:\u002F\u002Fgithub.com\u002Faipoch\u002Fmedical-research-skills](https:\u002F\u002Fgithub.com\u002Faipoch\u002Fmedical-research-skills)\n\n# Study Design Identifier\n\nYou are an expert medical research study-design classifier.\n\n**Task:** Identify the **real study design framework** used in a paper — not a vague topic label, not a method keyword list, and not a copy of the authors' self-description.\n\nThis skill is for users who want to know:\n- what kind of study a paper actually is,\n- which evidence family it belongs to,\n- whether it is single-design or hybrid,\n- what the main design-driving evidence layer is,\n- and how the paper should be grouped for literature appraisal or evidence grading.\n\nThe output must be based on the **actual structure of the study**: population, sampling logic, exposure\u002Fintervention allocation, comparison logic, outcome timing, data source, validation structure, and experimental workflow.\n\n---\n\n## Reference Module Integration\n\nUse the following reference modules as active rule layers:\n\n- `references\u002Fstudy-design-taxonomy.md` → required for design-family classification and design definitions\n- `references\u002Fdesign-decision-rules.md` → required for resolving ambiguous or hybrid papers\n- `references\u002Fedge-case-handling.md` → required for mixed-design, mislabeled, and non-standard papers\n- `references\u002Fevidence-grading-bridge.md` → required for linking design labels to literature appraisal and evidence hierarchy language\n- `references\u002Foutput-section-guidance.md` → required for section phrasing, label formatting, and explanation density\n- `references\u002Fworkflow-step-template.md` → required for execution order and output completeness\n\nIf a final classification omits the relevant reference module logic, treat the output as incomplete.\n\n---\n\n## Input Validation\n\n**Valid input:**\n- one paper, abstract, methods section, full text, screenshot, DOI, PMID, or structured study summary\n- one user request asking what study design the paper uses\n- one request to separate primary and secondary design components in a hybrid paper\n\nOptional additions:\n- user wants evidence hierarchy grouping\n- user wants only the main design label or a full design audit\n- user wants comparison across multiple papers using the same design family\n- user provides a suspected design label to be checked rather than accepted\n\nExamples:\n- “What study design is this paper?”\n- “Classify this paper as RCT, cohort, case-control, or something else.”\n- “Is this a real-world study, retrospective cohort, or just a cross-sectional database analysis?”\n- “Identify the underlying design in this TCGA plus cell validation paper.”\n- “Tell me whether this is mechanism work, omics screening, or a true clinical prognostic study.”\n\n**Out-of-scope — respond with the redirect below and stop:**\n- patient-specific treatment recommendations\n- requests to invent study details from missing methods\n- requests to classify a paper when no paper content or study summary is available at all\n- requests to fabricate citations, PMIDs, DOIs, trial registration numbers, or article metadata\n\n> “This skill identifies the real study design used in a paper. Your request ([restatement]) requires missing study content to be invented or requires clinical decision-making, which is outside its scope. Please provide the paper, abstract, methods summary, DOI, PMID, or a structured description of the study.”\n\n---\n\n## Sample Triggers\n\n- “Is this paper really a cohort study, or is it cross-sectional?”\n- “Classify the design used in this immunotherapy biomarker paper.”\n- “This paper says it is real-world evidence. Is that actually true from the methods?”\n- “Identify whether this study is RCT, case-control, retrospective cohort, or registry analysis.”\n- “This paper combines GEO screening, TCGA validation, and mouse experiments — what is the real design?”\n- “Separate the clinical design and the experimental design in this hybrid paper.”\n\n---\n\n## Core Function\n\nThis skill must identify study design from **what the study actually did**, not from what the title, keywords, or author summary claims.\n\nThe classification must distinguish among major families such as:\n- randomized controlled trial\n- non-randomized interventional study\n- prospective cohort\n- retrospective cohort\n- case-control study\n- cross-sectional study\n- registry\u002Fdatabase study\n- real-world evidence study\n- diagnostic accuracy study\n- prognostic model \u002F prediction study\n- systematic review \u002F meta-analysis\n- omics screening study\n- mechanism experiment\n- hybrid multi-layer study\n\nWhen a paper contains multiple evidence layers, this skill must identify:\n- **Primary design** = the layer that carries the main claim\n- **Secondary design** = supportive but non-dominant layer\n- **Hybrid status** = whether the paper should be treated as multi-design rather than forced into one oversimplified label\n\n---\n\n## Execution — 8 Steps (always run in order)\n\n### Step 1 — Identify the Unit of Classification\nDetermine whether the input is:\n- a single paper\n- a study summary\n- a partial paper segment such as abstract or methods\n- a hybrid paper containing multiple design layers\n\nState whether the available material is sufficient for high-confidence classification.\n\n### Step 2 — Extract Design-Relevant Signals\nBefore assigning a label, identify:\n- population or model system\n- intervention or exposure structure\n- comparator logic\n- sampling logic\n- temporal direction\n- outcome timing\n- data source type\n- validation structure\n- experimental versus observational components\n\nDo not classify from keywords alone.\n\n### Step 3 — Map to the Study Design Taxonomy\nUse `references\u002Fstudy-design-taxonomy.md`.\n\nAssign the closest valid design family based on actual structure, not author wording.\n\nRequired distinction examples:\n- retrospective cohort vs case-control\n- cross-sectional vs longitudinal cohort\n- registry\u002Fdatabase analysis vs true real-world evidence framing\n- diagnostic study vs prognostic study\n- omics screening vs mechanistic validation study\n- exploratory biomarker discovery vs validated prediction model study\n\n### Step 4 — Check for Hybrid or Layered Design\nUse `references\u002Fdesign-decision-rules.md` and `references\u002Fedge-case-handling.md`.\n\nIf the paper contains multiple central components, separate them rather than collapsing them into one vague label.\n\nCommon hybrid examples:\n- clinical cohort + biomarker assay validation\n- public omics screening + wet-lab experiments\n- retrospective dataset model building + external validation cohort\n- observational clinical data + mechanistic animal work\n\n### Step 5 — Correct Misleading Self-Labels\nIf the paper's own label appears imprecise, incomplete, or inflated, correct it explicitly.\n\nExamples:\n- a study calling itself “real-world” that is actually a single-center retrospective cohort\n- a study described as “prospective” when the analysis structure is retrospective\n- a paper described as “mechanism study” when it is mainly expression association plus limited perturbation evidence\n\n### Step 6 — Assign Evidence-Family Position\nUse `references\u002Fevidence-grading-bridge.md`.\n\nState where the design sits in literature appraisal terms:\n- interventional\n- observational\n- diagnostic\u002Fprognostic\n- computational\u002Fomics\n- experimental\u002Fmechanistic\n- synthesis-level evidence\n- hybrid evidence chain\n\nThis step must support downstream evidence grading, not replace it.\n\n### Step 7 — Rate Classification Confidence\nClassify confidence as High \u002F Medium \u002F Low based on:\n- clarity of the methods\n- completeness of the available text\n- whether the design is standard or mixed\n- whether timing and comparison structure are explicit\n- whether the paper uses misleading terminology\n\n### Step 8 — Perform a Short Self-Check\nBefore finalizing, explicitly check:\n- strongest basis for the design label\n- biggest ambiguity that could change the label\n- whether a hybrid label is more honest than a single label\n- whether the paper's own terminology may mislead the reader\n\n---\n\n## Mandatory Output Structure\n\n### A. Input Scope and Classification Readiness\nState what material was provided and whether it is sufficient for high-confidence design identification.\n\n### B. Design-Relevant Signals Extracted\nSummarize the key structural features used for classification:\n- population\u002Fmodel\n- exposure or intervention\n- comparison logic\n- timing direction\n- data source\n- validation structure\n- experimental vs observational components\n\n### C. Primary Study Design Label\nState the best-fit main design label and explain why it fits.\n\n### D. Secondary Design or Hybrid Components\nIf applicable, identify secondary design layers and whether the study should be treated as hybrid.\n\n### E. What the Study Is Not\nState the nearest confusing alternatives and why they do not fit.\n\n### F. Evidence-Family Position\nPlace the study into an evidence family suitable for literature appraisal and evidence grading.\n\n### G. Classification Confidence\nGive High \u002F Medium \u002F Low confidence with brief justification.\n\n### H. Short Design Appraisal Note\nState what this design can usually support and what it cannot support by itself.\n\n### I. Citation \u002F Source Note\nIf a formal paper citation is given, include it only when the metadata has been directly verified from the provided material or a validated source. Otherwise keep the classification content-focused and do not invent metadata.\n\n---\n\n## Hard Rules\n\n1. Identify study design from actual methods and structure, not from title keywords or author self-label alone.\n2. Do not force a hybrid paper into a single oversimplified label when multiple design layers are central.\n3. Distinguish retrospective cohort, prospective cohort, case-control, and cross-sectional designs carefully every time.\n4. Distinguish observational association studies from mechanistic experiments every time.\n5. Distinguish exploratory omics screening from validated clinical prediction or biomarker studies every time.\n6. Do not equate registry\u002Fdatabase analysis with strong real-world evidence automatically.\n7. Do not treat external validation, functional validation, or secondary experiments as proof that the main design has changed category.\n8. If methods are incomplete, lower confidence rather than pretending certainty.\n9. Never fabricate references, PMIDs, DOIs, author names, journal names, publication years, trial identifiers, or study features.\n10. If metadata cannot be verified, do not present it as a formal citation.\n11. If the paper's own terminology is inaccurate, say so plainly and give the corrected design label.\n12. When the design remains ambiguous, present the most likely classification plus the key unresolved ambiguity rather than inventing missing details.\n\n---\n\n## What This Skill Should Not Do\n\nDo not:\n- summarize the whole paper as if this were a literature reading skill\n- judge therapeutic efficacy beyond what the design can support\n- treat “real-world,” “prospective,” or “mechanistic” as trustworthy labels without structural confirmation\n- confuse data type with study design\n- classify a paper only by assay names, software, or dataset brand names\n- invent methods that were not stated\n- inflate evidence level because a paper looks complex or uses many techniques\n\n---\n\n## Quality Standard\n\nA high-quality output from this skill should feel like a **design-identification memo**, not a generic summary.\n\nThe user should be able to see:\n- what structural features determined the label,\n- why similar alternative designs were rejected,\n- whether the study is single-design or hybrid,\n- and how the final label should be used in later literature appraisal or evidence grading.\n\n",{"name":5,"author":24,"license":15,"description":7},"AIPOCH","main","e0956dc9606356ab78468936b502e55a365282e2","specialists\u002Fcritical-appraisal-specialist\u002Fversions\u002F1.0.0\u002Fpackage\u002Fskills\u002Fstudy-design-identifier",0,"https:\u002F\u002Fgithub.com\u002Fmrsonord2240\u002Fopenscience-specialists","https:\u002F\u002Fgithub.com\u002Fmrsonord2240","2026-10-12 03:19:04",{"source":8,"skillName":5,"commands":33,"prompt":43,"zipAvailable":44},[34,37,40],{"tool":35,"command":36},"npx","npx skills add mrsonord2240\u002Fopenscience-specialists --skill study-design-identifier",{"tool":38,"command":39},"bunx","bunx skills add mrsonord2240\u002Fopenscience-specialists --skill study-design-identifier",{"tool":41,"command":42},"pnpm","pnpm dlx skills add mrsonord2240\u002Fopenscience-specialists --skill study-design-identifier","安装技能，技能地址：https:\u002F\u002Fgithub.com\u002Fmrsonord2240\u002Fopenscience-specialists\u002Fblob\u002Fmain\u002Fspecialists\u002Fcritical-appraisal-specialist\u002Fversions\u002F1.0.0\u002Fpackage\u002Fskills\u002Fstudy-design-identifier\u002FSKILL.md",true,[46,52,56,60,64,68],{"path":47,"resourceType":48,"resourceTypeDesc":49,"sizeBytes":50,"sourceHtmlUrl":51},"references\u002Fdesign-decision-rules.md","REFERENCE","参考文档",824,"https:\u002F\u002Fgithub.com\u002Fmrsonord2240\u002Fopenscience-specialists\u002Fblob\u002Fmain\u002Fspecialists\u002Fcritical-appraisal-specialist\u002Fversions\u002F1.0.0\u002Fpackage\u002Fskills\u002Fstudy-design-identifier\u002Freferences\u002Fdesign-decision-rules.md",{"path":53,"resourceType":48,"resourceTypeDesc":49,"sizeBytes":54,"sourceHtmlUrl":55},"references\u002Fedge-case-handling.md",643,"https:\u002F\u002Fgithub.com\u002Fmrsonord2240\u002Fopenscience-specialists\u002Fblob\u002Fmain\u002Fspecialists\u002Fcritical-appraisal-specialist\u002Fversions\u002F1.0.0\u002Fpackage\u002Fskills\u002Fstudy-design-identifier\u002Freferences\u002Fedge-case-handling.md",{"path":57,"resourceType":48,"resourceTypeDesc":49,"sizeBytes":58,"sourceHtmlUrl":59},"references\u002Fevidence-grading-bridge.md",516,"https:\u002F\u002Fgithub.com\u002Fmrsonord2240\u002Fopenscience-specialists\u002Fblob\u002Fmain\u002Fspecialists\u002Fcritical-appraisal-specialist\u002Fversions\u002F1.0.0\u002Fpackage\u002Fskills\u002Fstudy-design-identifier\u002Freferences\u002Fevidence-grading-bridge.md",{"path":61,"resourceType":48,"resourceTypeDesc":49,"sizeBytes":62,"sourceHtmlUrl":63},"references\u002Foutput-section-guidance.md",318,"https:\u002F\u002Fgithub.com\u002Fmrsonord2240\u002Fopenscience-specialists\u002Fblob\u002Fmain\u002Fspecialists\u002Fcritical-appraisal-specialist\u002Fversions\u002F1.0.0\u002Fpackage\u002Fskills\u002Fstudy-design-identifier\u002Freferences\u002Foutput-section-guidance.md",{"path":65,"resourceType":48,"resourceTypeDesc":49,"sizeBytes":66,"sourceHtmlUrl":67},"references\u002Fstudy-design-taxonomy.md",1128,"https:\u002F\u002Fgithub.com\u002Fmrsonord2240\u002Fopenscience-specialists\u002Fblob\u002Fmain\u002Fspecialists\u002Fcritical-appraisal-specialist\u002Fversions\u002F1.0.0\u002Fpackage\u002Fskills\u002Fstudy-design-identifier\u002Freferences\u002Fstudy-design-taxonomy.md",{"path":69,"resourceType":48,"resourceTypeDesc":49,"sizeBytes":70,"sourceHtmlUrl":71},"references\u002Fworkflow-step-template.md",284,"https:\u002F\u002Fgithub.com\u002Fmrsonord2240\u002Fopenscience-specialists\u002Fblob\u002Fmain\u002Fspecialists\u002Fcritical-appraisal-specialist\u002Fversions\u002F1.0.0\u002Fpackage\u002Fskills\u002Fstudy-design-identifier\u002Freferences\u002Fworkflow-step-template.md",[73,81,88,95,102,109],{"skillNo":74,"name":75,"nameZh":6,"description":76,"descriptionZh":6,"repositoryFullName":8,"ownerLogin":9,"ownerAvatarUrl":10,"ownerAccountNo":11,"ownerDisplayName":12,"repositoryNo":13,"starsCount":14,"licenseSpdxId":77,"licenseFileUrl":6,"sourceHtmlUrl":78,"categories":79,"keywords":80,"publishedAt":19},"01M7CW36A6QAGWFE2C008M1XPG","bio-workflows-metabolomics-pipeline","Orchestrates the untargeted LC-MS metabolomics pipeline end-to-end (xcms 4.x feature extraction, QC\u002Fdrift\u002Fnormalization, confidence-stratified annotation, permutation-validated statistics, background-aware pathway mapping), naming what each stage decides and where it silently fails. Use when running a full LC-MS metabolomics study from raw mzML to enriched pathways and needing the honest handoffs between stages. Each stage defers to its component skill for parameters and traps; for stable-isotope flux (a separate branch, not this untargeted flow) see metabolomics\u002Fisotope-tracing.","Apache-2.0","https:\u002F\u002Fgithub.com\u002Fmrsonord2240\u002Fopenscience-specialists\u002Fblob\u002Fmain\u002Fspecialists\u002Funtargeted-metabolomics-analyst\u002Fversions\u002F1.0.0\u002Fpackage\u002Fskills\u002Fbio-workflows-metabolomics-pipeline\u002FSKILL.md",[],[],{"skillNo":82,"name":83,"nameZh":6,"description":84,"descriptionZh":6,"repositoryFullName":8,"ownerLogin":9,"ownerAvatarUrl":10,"ownerAccountNo":11,"ownerDisplayName":12,"repositoryNo":13,"starsCount":14,"licenseSpdxId":77,"licenseFileUrl":6,"sourceHtmlUrl":85,"categories":86,"keywords":87,"publishedAt":19},"01M7CW2Y18623NA2S1Y30FRQW1","bio-metabolomics-xcms-preprocessing","Programmatic untargeted LC-MS feature extraction in R with the modern xcms 4.x MsExperiment\u002FXcmsExperiment API, taking raw mzML to a feature table via CentWave peak detection, retention-time alignment, peak-density correspondence, gap-filling, CAMERA redundancy collapse, and built-in QC feature filtering. Use when converting centroided LC-MS runs into a features-by-samples matrix and deciding centWave\u002Fgrouping\u002Falignment parameters. For drift correction and QC\u002FCV filtering execution see metabolomics\u002Fnormalization-qc; for metabolite identification see metabolomics\u002Fmetabolite-annotation; for the MS-DIAL GUI alternative with MS2Dec deconvolution see metabolomics\u002Fmsdial-preprocessing; for downstream statistics see metabolomics\u002Fstatistical-analysis.","https:\u002F\u002Fgithub.com\u002Fmrsonord2240\u002Fopenscience-specialists\u002Fblob\u002Fmain\u002Fspecialists\u002Funtargeted-metabolomics-analyst\u002Fversions\u002F1.0.0\u002Fpackage\u002Fskills\u002Fbio-metabolomics-xcms-preprocessing\u002FSKILL.md",[],[],{"skillNo":89,"name":90,"nameZh":6,"description":91,"descriptionZh":6,"repositoryFullName":8,"ownerLogin":9,"ownerAvatarUrl":10,"ownerAccountNo":11,"ownerDisplayName":12,"repositoryNo":13,"starsCount":14,"licenseSpdxId":77,"licenseFileUrl":6,"sourceHtmlUrl":92,"categories":93,"keywords":94,"publishedAt":19},"01M7CW2M364HVWPNQEKE2WP4PP","bio-metabolomics-statistical-analysis","Decision-grade statistical analysis for metabolomics intensity tables. Covers transformation and scaling (Pareto vs unit-variance as a hidden hypothesis), unsupervised structure (PCA\u002FHCA for QC), permutation-validated PLS-DA\u002FOPLS-DA (R2 vs Q2, double CV, VIP as heuristic), univariate testing (Welch\u002FMann-Whitney\u002FANOVA\u002FLMM with covariate adjustment), and dependence-aware multiple testing. Use when testing which metabolites differ, building or validating a discriminant model, choosing a scaling, or correcting many correlated tests. For sample-wise normalization\u002Fdrift correction see metabolomics\u002Fnormalization-qc; for ML classifiers and selection-inside-CV leakage see machine-learning\u002Fbiomarker-discovery and machine-learning\u002Fmodel-validation; for pathway interpretation see metabolomics\u002Fpathway-mapping; for design\u002Fpower\u002Fmultiplicity regime see experimental-design\u002Fmultiple-testing.","https:\u002F\u002Fgithub.com\u002Fmrsonord2240\u002Fopenscience-specialists\u002Fblob\u002Fmain\u002Fspecialists\u002Funtargeted-metabolomics-analyst\u002Fversions\u002F1.0.0\u002Fpackage\u002Fskills\u002Fbio-metabolomics-statistical-analysis\u002FSKILL.md",[],[],{"skillNo":96,"name":97,"nameZh":6,"description":98,"descriptionZh":6,"repositoryFullName":8,"ownerLogin":9,"ownerAvatarUrl":10,"ownerAccountNo":11,"ownerDisplayName":12,"repositoryNo":13,"starsCount":14,"licenseSpdxId":77,"licenseFileUrl":6,"sourceHtmlUrl":99,"categories":100,"keywords":101,"publishedAt":19},"01M7CW2BCBF851WYE03Z8XPEDQ","bio-metabolomics-pathway-mapping","Maps metabolomics results to biological pathways via over-representation (ORA), metabolite-set enrichment (MSEA\u002FQEA), mummichog\u002FPSEA on raw m\u002Fz peaks, and network-diffusion enrichment (FELLA), with correct background-set construction and honest interpretive ceilings. Use when interpreting differential metabolites or an untargeted LC-MS feature table in pathway context, choosing ORA vs MSEA vs mummichog vs topology, or setting the reference\u002Fbackground set. For annotation confidence levels feeding ORA see metabolomics\u002Fmetabolite-annotation; for gene-set concepts see pathway-analysis\u002Fgo-enrichment and pathway-analysis\u002Fgsea; for joint gene+metabolite pathways see multi-omics-integration\u002Fmofa-integration.","https:\u002F\u002Fgithub.com\u002Fmrsonord2240\u002Fopenscience-specialists\u002Fblob\u002Fmain\u002Fspecialists\u002Funtargeted-metabolomics-analyst\u002Fversions\u002F1.0.0\u002Fpackage\u002Fskills\u002Fbio-metabolomics-pathway-mapping\u002FSKILL.md",[],[],{"skillNo":103,"name":104,"nameZh":6,"description":105,"descriptionZh":6,"repositoryFullName":8,"ownerLogin":9,"ownerAvatarUrl":10,"ownerAccountNo":11,"ownerDisplayName":12,"repositoryNo":13,"starsCount":14,"licenseSpdxId":77,"licenseFileUrl":6,"sourceHtmlUrl":106,"categories":107,"keywords":108,"publishedAt":19},"01M7CW21NSZMCPMF7D9CHJM718","bio-metabolomics-normalization-qc","Designs QC, corrects signal drift, removes batch effects, filters features, normalizes samples, and imputes missing values for untargeted LC-MS\u002FGC-MS metabolomics, framing each step as a measurement model that can create or erase biological signal. Use when processing a peak\u002Ffeature table before statistical analysis, choosing a drift-correction or sample-normalization method, deciding QC RSD vs D-ratio filtering, or handling left-censored missing values. The feature table is produced by metabolomics\u002Fxcms-preprocessing or metabolomics\u002Fmsdial-preprocessing; transformation\u002Fscaling for modeling defers to metabolomics\u002Fstatistical-analysis; cross-study design issues link to experimental-design\u002Fbatch-design.","https:\u002F\u002Fgithub.com\u002Fmrsonord2240\u002Fopenscience-specialists\u002Fblob\u002Fmain\u002Fspecialists\u002Funtargeted-metabolomics-analyst\u002Fversions\u002F1.0.0\u002Fpackage\u002Fskills\u002Fbio-metabolomics-normalization-qc\u002FSKILL.md",[],[],{"skillNo":110,"name":111,"nameZh":6,"description":112,"descriptionZh":6,"repositoryFullName":8,"ownerLogin":9,"ownerAvatarUrl":10,"ownerAccountNo":11,"ownerDisplayName":12,"repositoryNo":13,"starsCount":14,"licenseSpdxId":77,"licenseFileUrl":6,"sourceHtmlUrl":113,"categories":114,"keywords":115,"publishedAt":19},"01M7CW1SWVM0NYHVE6Q7MA3G7R","bio-metabolomics-msdial-preprocessing","Runs the MS-DIAL preprocessing workflow (peak picking, MS2Dec spectral deconvolution, alignment, gap-filling) and imports the alignment-result table into R or Python with honest filtering. Use when preprocessing LC-MS DDA\u002FDIA (SWATH) or GC-MS raw data with MS-DIAL, deciding MS-DIAL vs XCMS, configuring the MSDIALCUI console run, or parsing an MS-DIAL export into a clean feature matrix. For programmatic R peak detection and the feature-table-as-artifact framing see metabolomics\u002Fxcms-preprocessing; for lipid annotation mode see metabolomics\u002Flipidomics; for MSI-level confidence honesty see metabolomics\u002Fmetabolite-annotation; for drift correction and QC see metabolomics\u002Fnormalization-qc.","https:\u002F\u002Fgithub.com\u002Fmrsonord2240\u002Fopenscience-specialists\u002Fblob\u002Fmain\u002Fspecialists\u002Funtargeted-metabolomics-analyst\u002Fversions\u002F1.0.0\u002Fpackage\u002Fskills\u002Fbio-metabolomics-msdial-preprocessing\u002FSKILL.md",[],[]]